1. Home
  2. UP vs MOLN Comparison

UP vs MOLN Comparison

Compare UP & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$6.21

Market Cap

182.3M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.12

Market Cap

154.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
MOLN
Founded
2013
2004
Country
United States
Switzerland
Employees
1250
N/A
Industry
Aerospace
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
182.3M
154.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UP
MOLN
Price
$6.21
$4.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
77.1K
2.7K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$374.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$3.46
52 Week High
$10.09
$5.36

Technical Indicators

Market Signals
Indicator
UP
MOLN
Relative Strength Index (RSI) 45.04 54.97
Support Level $0.49 $3.65
Resistance Level $6.77 $4.49
Average True Range (ATR) 0.48 0.08
MACD -0.04 0.00
Stochastic Oscillator 58.55 75.47

Price Performance

Historical Comparison
UP
MOLN

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: